saxenda glp 1 (liraglutide) for the Treatment of Obesity, US Saxenda Boosted Weight Loss, Especially
Description
Hendriks FK, Kooman JP, van Loon LJC
The contents do not represent the views of the US Department of Veterans Affairs or the US government
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena
Many users find they need to focus on food choices that provide adequate nutrition in smaller volumes, especially protein to preserve muscle mass during weight loss
Addressing these issues through appropriate treatments and lifestyle changes is crucial to managing and effectively overcoming weight gain
Back Knudsen, B, Lau, J (12 April 2019) 'The discovery and development of Liraglutide and Semaglutide', Frontiers in Endocrinology
